Stocks and Investing
Stocks and Investing
Tue, April 26, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Andrew Mok Maintained (UHS) at Strong Sell with Decreased Target to $129 on, Apr 26th, 2022
Andrew Mok of UBS, Maintained "Universal Health Services, Inc." (UHS) at Strong Sell with Decreased Target from $134 to $129 on, Apr 26th, 2022.
Andrew has made no other calls on UHS in the last 4 months.
There are 8 other peers that have a rating on UHS. Out of the 8 peers that are also analyzing UHS, 4 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Ben Hendrix of "RBC Capital" Maintained at Hold with Decreased Target to $149 on, Monday, March 7th, 2022
- Joseph France of "Seaport Global" Downgraded from Strong Buy to Hold on, Monday, February 28th, 2022
- Sarah James of "Piper Sandler" Maintained at Hold with Increased Target to $145 on, Monday, February 28th, 2022
- Whit Mayo of "SVB Leerink" Maintained at Hold with Increased Target to $139 on, Monday, February 28th, 2022
These are the ratings of the 4 analyists that currently disagree with Andrew
- Stephen Baxter of "Wells Fargo" Initiated at Sell and Held Target at $139 on, Tuesday, March 29th, 2022
- Ann Hynes of "Mizuho" Maintained at Strong Buy with Increased Target to $164 on, Thursday, March 3rd, 2022
- Jason Cassorla of "Citigroup" Maintained at Strong Buy with Increased Target to $167 on, Tuesday, March 1st, 2022
- Steven Valiquette of "Barclays" Maintained at Sell and Held Target at $145 on, Friday, February 25th, 2022
Contributing Sources